Medical News Today -
13 Nov 2013 19:00
The novel compound IRL-1620 may be useful in treating Alzheimer's disease (AD) as it has been shown to prevent cognitive impairment and oxidative stress in animal models. This research is being presented at the 2013 American Association of Pharmaceutical Scientists (AAPS) Annual Meeting and Exposition, the world's largest pharmaceutical sciences meeting, in San Antonio, Nov. 10 - 14. AD is a form of dementia that worsens over time, leading to a slow decline in cognitive functions and affecting m...
Share this Article